JAZZ icon

Jazz Pharmaceuticals
JAZZ

Overview Fund Activity

426 hedge funds and large institutions have $7.36B invested in Jazz Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 73 funds opening new positions, 185 increasing their positions, 116 reducing their positions, and 60 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
426
Holders Change
+9
Holders Change %
+2.16%
% of All Funds
9.23%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.13%
New
73
Increased
185
Reduced
116
Closed
60
Calls
$26.5M
Puts
$37.5M
Net Calls
-$11.1M
Net Calls Change
-$3.02M

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
$285M
2
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans
Minnesota
$78.2M
3
Two Sigma Advisers
Two Sigma Advisers
New York
$76M
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
$323M
5
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
$49.8M

Top Sellers

1
PI
Putnam Investments
Massachusetts
$183M
2
Fidelity Investments
Fidelity Investments
Massachusetts
$488M
3
Westfield Capital Management
Westfield Capital Management
Massachusetts
$0
4
VOYA Investment Management
VOYA Investment Management
Georgia
$2.39M
5
SIG
Senator Investment Group
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
HNB
476
Huntington National Bank
Ohio
– -$3K -27 Closed
CAM
477
ClariVest Asset Management
California
– -$2K -15 Closed
BFEC
478
Benjamin F. Edwards & Company
Missouri
– -$1K -11 Closed
W
479
WealthOne
New York
– -$1K -10 Closed
EWM
480
Executive Wealth Management
Michigan
– -$1K -9 Closed
16 17 18 19
20